Compare DELL & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DELL | PFE |
|---|---|---|
| Founded | 1984 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.5B | 155.2B |
| IPO Year | 2013 | 2013 |
| Metric | DELL | PFE |
|---|---|---|
| Price | $209.02 | $26.41 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 14 |
| Target Price | ★ $181.63 | $29.29 |
| AVG Volume (30 Days) | 5.2M | ★ 25.3M |
| Earning Date | 05-28-2026 | 05-05-2026 |
| Dividend Yield | 1.23% | ★ 6.55% |
| EPS Growth | ★ 36.05 | N/A |
| EPS | ★ 8.68 | 1.36 |
| Revenue | ★ $113,538,000,000.00 | $62,579,000,000.00 |
| Revenue This Year | $26.19 | N/A |
| Revenue Next Year | $8.60 | N/A |
| P/E Ratio | $23.97 | ★ $19.61 |
| Revenue Growth | ★ 18.80 | N/A |
| 52 Week Low | $92.53 | $21.97 |
| 52 Week High | $221.50 | $28.75 |
| Indicator | DELL | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 64.52 | 42.84 |
| Support Level | $116.09 | $24.99 |
| Resistance Level | N/A | $26.65 |
| Average True Range (ATR) | 8.31 | 0.51 |
| MACD | -0.74 | -0.10 |
| Stochastic Oscillator | 71.96 | 12.46 |
Dell Technologies is a broad information technology vendor, primarily supplying hardware to enterprises. It focuses on premium and commercial personal computers, as well as enterprise on-premises data center hardware. It holds top-three shares in its core markets of personal computers, peripheral displays, mainstream servers, and external storage. Dell has a robust ecosystem of component and assembly partners and also relies heavily on channel partners to fulfill its sales.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.